Search This Blog

Thursday, October 24, 2019

Anika Therapeutics EPS beats by $0.25, beats on revenue

Anika Therapeutics (NASDAQ:ANIK): Q3 GAAP EPS of $0.64 beats by $0.25.
Revenue of $29.7M (+10.9% Y/Y) beats by $2.69M.
Press Release
https://seekingalpha.c
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)